Therapies & Clinical Trial Matching with MEDITECH & GenomOncology
Watch a 30-minute on-demand webinar where MEDITECH’s Manager of Clinical Product Management, Jennifer Ford, and GenomOncology’s Vice President of Product Innovation, James Cole, PhD, dive into how our integrated solutions empower clinicians and researchers to develop impactful treatment strategies.
During the webinar, gain insight into:
- How MEDITECH enhanced its Expanse Genomics solution by integrating evidence-based guidance for therapies and clinical trial matching through GenomOncology.
- The impact and results of this partnership within precision medicine care.
- How this integrated data is visually displayed within the EHR, improving accessibility and usability for healthcare professionals.
Featured Presenters
James Cole, PhD
Vice President of Product Innovation, GenomOncology
James Cole has over a decade of experience in precision oncology, making him integral in GenomOncology's understanding of the field of clinical genomics. Cole works across GenomOncology’s Precision Oncology Platform (POP), ensuring all our precision oncology solutions include the necessary precision oncology data sets in order to inform decision support and streamline patient treatment analysis and research.
Jennifer Ford, MBA
Manager of Clinical Product Management, MEDITECH
Jennifer Ford works with the leadership of MEDITECH, development, marketing, and service as well as customers and industry representatives to drive the future strategy of Genomics within Electronic Health Records. Her expertise in genomics, laboratory information systems, healthcare software, and bioinformatics has made her a key member of the MEDITECH team that developed Expanse Genomics. Jen holds certificates in Genetics, Cancer Genomics and Precision Medicine, and Genetic Testing and Sequencing Technologies from Harvard Medical. Her continued dedication to genomic medicine fuels her with the knowledge needed to propel the company’s ground-breaking development of solutions that are making precision medicine possible at any healthcare organization.